THC
Tenet Healthcare Corporation · Healthcare · Medical - Care Facilities
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 136 | +1 | 64.22M | $12.02B | +9 | −10 |
| Q1 2026 | 140 | -6 | 67.35M | $12.71B | +5 | −12 |
| Q4 2025 | 146 | 0 | 74.52M | $14.80B | +2 | −1 |
| Q3 2025 | 23 | 0 | 47.80M | $9.71B | — | −1 |
| Q2 2025 | 21 | 0 | 49.65M | $8.73B | +1 | −1 |
| Q1 2025 | 18 | +1 | 24.64M | $3.31B | +1 | — |
| Q4 2024 | 17 | -2 | 22.85M | $2.89B | — | −2 |
| Q3 2024 | 18 | 0 | 21.19M | $3.52B | — | — |
| Q2 2024 | 18 | — | 23.95M | $3.19B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 8.02M | — | $1.07B | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 2 | Glenview Capital ✦ | 4.67M | — | $620.68M | 13.1% | n/c | 1 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 2.14M | — | $284.42M | 0.3% | n/c | 1 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (passive) | 1.78M | — | $237.33M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 1.65M | — | $220.14M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 6 | Millennium Management ✦ | 1.56M | — | $208.18M | 0.2% | n/c | 1 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 1.38M | — | $183.33M | 0.2% | n/c | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 713.98K | — | $94.98M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Greenlight Capital (DME Capital) ✦ | 597.68K | — | $79.51M | 3.9% | n/c | 1 | SEC ↗ ×2 |
| 10 | AQR Capital Management ✦ | 341.25K | — | $45.40M | 0.1% | n/c | 1 | SEC ↗ ×3 |
| 11 | Point72 Asset Management ✦ | 336.26K | — | $44.73M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 299.64K | — | $39.86M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 206.38K | — | $27.45M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 96.64K | — | $12.86M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 86.82K | — | $11.55M | 0.1% | n/c | 1 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 46.53K | — | $6.19M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 17 | Two Sigma Investments ✦ | 14.60K | — | $1.94M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Harris Associates (Oakmark) ✦ | 3.90K | — | $518,817 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 686 holders, 81.68M shares, $13.63B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 4.03K sh · $1.06M
Director · 5.48K sh · $1.44M
Director · 2.50K sh · $662,079
Director · 10.00K sh · $2.63M
Officer · 24.00K sh · $6.39M
Officer, Director · 7.90K sh · $2.17M
Officer, Director · 17.22K sh · $4.71M
Officer, Director · 24.88K sh · $6.82M
Officer, Director · 36.66K sh · $10.22M
Officer, Director · 13.34K sh · $3.71M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology